Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Energy conservation for fatigue management in multiple sclerosis: a pilot randomized controlled trial.
Management of optic neuritis as a clinically first event of multiple sclerosis.
Complications of Immunosuppressive/Immunomodulatory Therapy in Neurological Diseases.
CD5-positive B cell subsets in secondary progressive multiple sclerosis.
Multiple Sclerosis: A Disease of Affluence?.
Identifying and treating pain caused by MS.
Blood-Brain Barrier Alterations in the Cerebral Cortex in Experimental Autoimmune Encephalomyelitis.
New TYSABRI® analysis at AAN annual meeting shows improved walking speed in significant number of MS patients
Progression of multiple sclerosis is associated with gender differences in glutathione S-transferase P1 detoxification pathway.
Quantification of gait kinematics and walking ability of people with multiple sclerosis who are new users of functional electrical stimulation.
HLA-DRB1 does not have a role in clinical response to interferon-beta among Iranian multiple sclerosis patients.
The medicalisation of revolt: a sociological analysis of medical cannabis users.
Cognitive function in multiple sclerosis: a subcortical pattern of neuropsychological impairment?
A rare presentation of atypical demyelination: tumefactive multiple sclerosis causing Gerstmann's syndrome.
Influence of melatonin supplementation on serum antioxidative properties and impact of the quality of life in multiple sclerosis patients.
Contrast enrichment of spinal cord MR imaging using a ratio of T1-weighted and T2-weighted signals.
Critical role for PDE4 subfamilies in the development of experimental autoimmune encephalomyelitis.
[Assessment of the risk of the transition of a monofocal clinically isolated syndrome to clinically definite multiple sclerosis.]
Adolescents' experiences on coping with parental multiple sclerosis: a grounded theory study.
Glia in mammalian development and disease.
Validity and reliability of the Serbian version of Patient-Reported Impact of Spasticity Measure in multiple sclerosis.
[Neuromyelitis optica: a case report].
Glutamate gene polymorphisms predict brain volumes in multiple sclerosis.
CC3-03: Drug Characteristics Associated with Medication Adherence Across Eight Disease States.
Cannabis for spasticity and multiple sclerosis
Pages
« first
‹ previous
…
227
228
229
230
231
232
233
234
235
…
next ›
last »